This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Billionaire Tom Steyer has shattered spending records with a $195 million political ad blitz this year, dwarfing riva...
A fresh look at a chilling historical echo: the 1987 omen: kevin warsh's. As markets brace for a new Fed chair, inves...
Planned Parenthood and two regional providers resume Medicaid billing for non-abortion services after funding cuts re...
This in-depth look breaks down Unity's Q1 2026 earnings call, outlining revenue drivers, profitability, and what the ...
Intel’s 2026 comeback stunned many investors. This article breaks down the core reason behind the rally and what it c...
CrowdStrike delivered a strong quarter, beating earnings and lifting full-year guidance, and even announced a 4-for-1...
Alphabet surged over the past year, but a 10% pullback from its high has investors wondering if now is the moment to ...
Defi hacks turning high yields into a hidden tax are drawing fresh scrutiny, as Q2 losses from hacks totaled $780.3 m...
Microsoft shifts core apps to its MAI system, pressuring margins while Google leans on in‑house silicon and Gemini. A...
A strong quarter from TSMC is more than a one-off beat. This analysis explains why tsmc's revenue grew last and how c...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...